JPS57870B2 - - Google Patents

Info

Publication number
JPS57870B2
JPS57870B2 JP2200774A JP2200774A JPS57870B2 JP S57870 B2 JPS57870 B2 JP S57870B2 JP 2200774 A JP2200774 A JP 2200774A JP 2200774 A JP2200774 A JP 2200774A JP S57870 B2 JPS57870 B2 JP S57870B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP2200774A
Other versions
JPS49134694A (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS49134694A publication Critical patent/JPS49134694A/ja
Publication of JPS57870B2 publication Critical patent/JPS57870B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2200774A 1973-03-12 1974-02-26 Expired JPS57870B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00340113A US3845071A (en) 1973-03-12 1973-03-12 Imidazo(1,2-a)azacycloalkanes

Publications (2)

Publication Number Publication Date
JPS49134694A JPS49134694A (ja) 1974-12-25
JPS57870B2 true JPS57870B2 (ja) 1982-01-08

Family

ID=23331947

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2200774A Expired JPS57870B2 (ja) 1973-03-12 1974-02-26

Country Status (10)

Country Link
US (1) US3845071A (ja)
JP (1) JPS57870B2 (ja)
BE (1) BE812061A (ja)
CA (1) CA1028324A (ja)
CH (1) CH602724A5 (ja)
DE (1) DE2409262A1 (ja)
FR (1) FR2221142B1 (ja)
GB (1) GB1417104A (ja)
NL (1) NL7402025A (ja)
ZA (1) ZA74734B (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5745069U (ja) * 1980-08-27 1982-03-12
JPH0130234B2 (ja) * 1981-05-15 1989-06-16 Hitachi Ltd

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1048269B (it) * 1973-03-01 1980-11-20 Shell Int Research Processo per ridurre il contenuto totale di zolfo di gas di scarico del processo claus
US5198433A (en) * 1988-06-28 1993-03-30 Merrell Dow Pharmaceuticals Inc. Lactamimides as calcium antagonists
US5082837A (en) * 1988-06-28 1992-01-21 Merrell Dow Pharmaceuticals Lactamimides as calcium antagonists
US5010072A (en) * 1988-06-28 1991-04-23 Merrell Dow Pharmaceuticals Inc. Lactamimides as calcium antagonists
CA2134009C (en) * 1993-11-11 2005-03-08 Oleg Werbitzky Bicyclic amidines, process for their preparation, and their use as catalyst

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5745069U (ja) * 1980-08-27 1982-03-12
JPH0130234B2 (ja) * 1981-05-15 1989-06-16 Hitachi Ltd

Also Published As

Publication number Publication date
CA1028324A (en) 1978-03-21
CH602724A5 (ja) 1978-07-31
FR2221142A1 (ja) 1974-10-11
US3845071A (en) 1974-10-29
FR2221142B1 (ja) 1977-02-18
DE2409262A1 (de) 1974-09-19
GB1417104A (en) 1975-12-10
ZA74734B (en) 1974-12-24
NL7402025A (ja) 1974-09-16
JPS49134694A (ja) 1974-12-25
BE812061A (fr) 1974-07-01

Similar Documents

Publication Publication Date Title
AR201758A1 (ja)
AU476761B2 (ja)
AU465372B2 (ja)
AU474593B2 (ja)
AU474511B2 (ja)
AU474838B2 (ja)
AU465453B2 (ja)
AU465434B2 (ja)
AU471343B2 (ja)
AU450229B2 (ja)
AU476714B2 (ja)
JPS5012076A (ja)
FR2221142B1 (ja)
AU472848B2 (ja)
AU466283B2 (ja)
AU476696B2 (ja)
AU477823B2 (ja)
AR210729A1 (ja)
AU471461B2 (ja)
AU461342B2 (ja)
AU476873B1 (ja)
AU447540B2 (ja)
AU1891376A (ja)
AU479422A (ja)
AU479458A (ja)